Why Healthcare AI's Biggest Bottleneck Isn't Data Volume—It's Data Diversity
Medical imaging platform Segmed argues that building robust AI diagnostic tools depends less on massive datasets than on curated, multi-site imaging that reflects real-world clinical variation.
Illustration: AI-generated
As healthcare AI companies race to develop the next generation of diagnostic tools, a critical infrastructure challenge is emerging: the problem isn't finding enough medical images—it's finding the right mix of images that reflect the messy reality of clinical practice across different hospitals, scanner types, and patient populations.
Segmed, a medical imaging data platform, is positioning itself at the center of this challenge by offering what it describes as essential infrastructure for AI development. The company operates a centralized repository of millions of de-identified imaging studies sourced from diverse vendors and care settings, emphasizing that data breadth—not just volume—is the key constraint in building generalist medical imaging foundation models.
Curated Cohorts Link Imaging to Clinical Outcomes
At the heart of Segmed's offering is its PRISM Pre-Built Research Series, which provides multimodal cohorts that link real-world imaging data with electronic health record clinical information and longitudinal patient outcomes. These pre-built datasets span multiple disease areas and imaging modalities, designed to accelerate AI validation, biomarker discovery, and real-world evidence generation.
Current PRISM offerings include cohorts focused on prostate cancer with PSMA insights, GLP-1 therapies with longitudinal outcomes and biomarkers, and amyloid-targeting treatments in brain imaging. The platform provides secure access to CT and MRI scans that pharmaceutical companies, AI developers, device makers, health systems, and clinical research organizations can use for model development and validation.
According to the company, this approach addresses a growing regulatory expectation: that AI models be trained and validated on representative, multi-site datasets with clear separation between training and validation sources. As regulators scrutinize healthcare AI more closely, demonstrating that models generalize across different clinical settings and patient populations has become increasingly important.
Addressing the Infrastructure Gap in Medical AI
Segmed's framework is designed to enable compliant data sharing while mitigating privacy and security concerns through de-identification and curation. For healthcare providers, participation in the platform offers a way to contribute imaging data for research while maintaining regulatory compliance, potentially creating new revenue streams and research collaboration opportunities.
For pharmaceutical companies, the pre-built disease-specific imaging cohorts promise to reduce the time-consuming process of negotiating data access agreements with multiple institutions. This could accelerate biomarker discovery, drug development timelines, and the generation of real-world evidence needed for regulatory submissions.
The company's emphasis on diversity over volume reflects a broader recognition in the AI community that models trained on narrow datasets—even very large ones—may fail when deployed in different clinical environments with different scanner protocols, patient demographics, or imaging techniques.
Looking Ahead
CEO David Gascoigne is scheduled to participate in the LSI Europe 2026 conference, where the company is expected to further articulate its vision for becoming critical infrastructure in the healthcare AI ecosystem.
For AI developers, access to diverse, multi-site imaging datasets with EHR linkage could address what Segmed identifies as the data breadth bottleneck in foundation model development. For patients, the promise is that broader, more representative training datasets will improve AI model generalizability across different scanner types and care settings, potentially reducing algorithmic bias and improving diagnostic accuracy across diverse populations.
As healthcare AI moves from research prototypes to clinical deployment, the infrastructure for assembling, curating, and sharing medical imaging data at scale may prove as important as the algorithms themselves.
Sources
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.